Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 1.017M
March 31, 2026 0.6895M
December 31, 2025 0.2786M
September 30, 2025 0.2725M
June 30, 2025 0.2681M
March 31, 2025 44.09M
December 31, 2024 0.22M
September 30, 2024 43.28M
June 30, 2024 43.28M
March 31, 2024 43.22M
December 31, 2023 42.97M
September 30, 2023 36.34M
June 30, 2023 36.33M
March 31, 2023 36.28M
December 31, 2022 36.14M
September 30, 2022 36.13M
Date Value
June 30, 2022 35.98M
March 31, 2022 30.15M
December 31, 2021 30.07M
September 30, 2021 29.87M
June 30, 2021 29.66M
March 31, 2021 29.58M
December 31, 2020 29.54M
September 30, 2020 29.49M
June 30, 2020 29.49M
March 31, 2020 29.40M
December 31, 2019 26.87M
September 30, 2019 26.84M
June 30, 2019 26.84M
March 31, 2019 26.84M
June 30, 2018 0.1342M
March 31, 2018 26.84M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Korsana Biosciences, Inc. 0.608M
PepGen Inc. 69.26M
Q32 Bio, Inc. 23.74M
Bridgebio Oncology Therapeutics, Inc. 80.12M
Arrowhead Pharmaceuticals, Inc. 141.14M